COVID-19 impact on pathological cancer diagnoses in Netherlands, Aotearoa New Zealand, & N. Ireland

por Mitchell, H, McLean, J, Gavin, A T, Visser, O, Millar, E, Luff, T, Bennett, D
Publicado 2023

FAB: First UK feasibility trial of a future randomised controlled trial of Family focused treatment for Adolescents with Bipolar disorder

por Sharma, A., Glod, M., Forster, T., McGovern, R., McGurk, K., Barron Millar, E., Meyer, T. D., Miklowitz, D., Ryan, V., Vale, L., Le Couteur, A.
Publicado 2020

Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53

por Millar, E K A, Graham, P H, McNeil, C M, Browne, L, O'Toole, S A, Boulghourjian, A, Kearsley, J H, Papadatos, G, Delaney, G, Fox, C, Nasser, E, Capp, A, Sutherland, R L
Publicado 2011

BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast

por Millar, E K A, Anderson, L R, McNeil, C M, O'Toole, S A, Pinese, M, Crea, P, Morey, A L, Biankin, A V, Henshall, S M, Musgrove, E A, Sutherland, R L, Butt, A J
Publicado 2009

The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy

por Tan, E Y, Yan, M, Campo, L, Han, C, Takano, E, Turley, H, Candiloro, I, Pezzella, F, Gatter, K C, Millar, E K A, O'Toole, S A, McNeil, C M, Crea, P, Segara, D, Sutherland, R L, Harris, A L, Fox, S B
Publicado 2009